Genetic considerations for a woman's annual gynaecological examination

R. Douglas Wilson, Sylvie Langlois, SOGC GENETICS COMMITTEE, François Audibert, Jo‐Ann Brock, June Carroll, Lola Cartier, Valérie Désilets, Alain Gagnon, Jo-Ann Johnson, Lynn Murphy‐Kaulbeck, Nanette Okun, Melanie Pastuck, Vyta Senikas
Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC · 2012 · vol. 34(3) , pp. 276–284 · doi:10.1016/s1701-2163(16)35189-1 · PMID:22385672 · W2137451411
Guideline OA: closed CC0
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by qwen3.7-flash, 2026-08-29 ⓘ

This committee opinion provides an overview of common genetic conditions to consider during annual gynaecological assessments, aiming to improve risk management and diagnostic opportunities for women.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

OBJECTIVE: To provide the physician with an overview of common genetic conditions that should be considered during a women's annual gynaecological assessment to determine the patient's risk or to initiate specific testing or referral to another subspecialty service, depending on personal or family history. OPTIONS: This genetic information can be used for patient education and possible disease and/or mutation screening or diagnosis. OUTCOMES: The use of this genetic information may allow improved risk-benefit assessment and management at the annual gynaecological examination. EVIDENCE: Studies published in English up to and including May 2010 were retrieved through searches of PubMed and the Cochrane Library, using appropriate controlled vocabulary (gynaecological diagnosis, genetic inheritance) and key words (genetic risk, genetic mutation, inheritance, family history, uterus, ovary, endometrial, vagina, colon, gastric, renal, breast, cardiac, thrombophilia, diabetes, epilepsy, leiomyomata uteri). Other literature sources were identified through searching the web sites of health technology assessment and health technology assessment-related agencies, clinical practice guideline collections, clinical trial registries, and national and international medical specialty societies. VALUES: The levels of evidence are not adequate for evidence-based recommendations to be made. BENEFITS, HARMS, AND COSTS: This committee opinion will enhance the use of new genetic knowledge and its application to the annual gynaecological care of women. Risk management and diagnostic opportunities for genetic gynaecological conditions will be improved. A more complete understanding of genetic conditions may increase anxiety and psychological stress for women and their families. SPONSORS: Society of Obstetricians and Gynaecologists of Canada. RECOMMENDATIONS: The levels of evidence are not adequate for evidence-based recommendations to be made.

My notes (saved in your browser only)

MeSH descriptors

Genetic Diseases, Inborn Gynecological Examination Canada Female Genetic Diseases, Inborn Genetic Testing Humans Risk Assessment

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

References (45)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:10:02.438825+00:00
unpaywall
last seen: 2026-10-09T06:36:44.367587+00:00
License: CC0 · commercial use OK